[ad_1]
In the United States, the first case of allergic reaction the anti-Covid vaccine manufactured by the corporate duo Pfizer-BioNTech, whose administration to the American population began earlier this week. The subject showing intolerance to the serum would be a health worker on duty at a hospital in theAlaska, remained anonymous for the time being. The woman had received the vaccine on Tuesday and reportedly experienced anaphylactic rejection symptoms as early as 10 minutes after inoculating the antidote. After the UK, the US also witnessed a case of an allergic reaction to the Pfizer-BioNTech serum, with the health authorities of the two countries, however, immediately calling on citizens and the press not to panic. and at the same time, it minimized the abnormal reactions to the vaccine that have occurred thus far.
In detail, the first case of allergic reaction occurred in the United States would have involved an employee of the medical staff of the Bartlett Regional Hospital in Juneau, the capital of Alaska. Ten minutes after the administration of the serum, the woman allegedly experienced progressive redness of her body, particularly on the face and chest, along with breathing difficulties and tachycardia.
According to local health officials, the unfortunate woman was consequently subjected to close observation by hospital doctors, finally being transferred, as a precaution, to the intensive care unit of the center.
Dr. Lindy Jones provided US broadcasters with more information on how Bartlett Regional Hospital medical staff treated that woman’s allergic reaction to the Covid vaccine, who personally determined that worker’s health status. .
He said that to curb the ongoing anaphylactic storm in the unfortunate’s body, this patient was given intramuscular injections of adrenaline, combined with the administration of antihistamines and specific steroids. the protocol The antiallergic reactions adopted in the case in question by the doctors of the Juneau clinic would be the official ones developed for days by the state health authorities, ready to be applied precisely in the event that people who have just been vaccinated against the coronavirus experience symptoms abnormal.
The unfortunate, Jones confirmed, would be much better now, after a night of the same past as a precaution in intensive care, and would be literally thrilled to have received, despite the aforementioned complications, immunity to Covid.
In going to reconstruct the medical history of the woman in question, it emerged, Jones continued, that she, in the past, had never shown symptoms of allergy to vaccines. However, he invited the population not to give in to irrational fears, highlighting for this that the anomalous reaction of the woman to the anti-Covid serum was effectively counteracted by health workers, in application of the corresponding emergency protocols in force in Alaska . and throughout the United States.
Dr. Jay Butler, an official with the US Centers for Disease Control and Prevention, immediately gave Juneau physicians compliments as well as praise for the protocols mentioned. The representative of this federal agency in fact presented the speed with which the Alaska doctors squashed the anaphylactic reaction of that woman to the Pfizer-BioNTech antidote as a demonstration that “the system works”.
Later, Paul Offit, a consultant to the Food and Drug Administration (FDA), gave the stars and stripes further assurances about the efficacy and safety of the anti-coronavirus serum. He then assured that the American health system is well prepared to face possible situations of individual allergic reactions to the vaccine after having received news of the two cases of anaphylactic rejection that occurred recently in the United Kingdom.
Finally, the luminaire specified that citizens who have previously had allergic reactions to a vaccine should not, for the moment, be inoculated with Pfizer-BioNTech serum, for precautionary reasons and until scientists have discovered which specific component of the vaccine. The mentioned antidote triggers allergic reactions in some people. At the same time, Offit estimated that the percentage of people prone to allergic reactions to the new serum, out of the millions and millions of people who are about to be vaccinated, would remain derisory. Consequently, there are currently no serious precautionary grounds for suspending the ongoing immunization campaigns in the US and around the world, which are based precisely on the inoculation of the Pfizer-BioNTech product.
